AU4834799A - Human az-1 gene, variants thereof and expressed gene products - Google Patents

Human az-1 gene, variants thereof and expressed gene products

Info

Publication number
AU4834799A
AU4834799A AU48347/99A AU4834799A AU4834799A AU 4834799 A AU4834799 A AU 4834799A AU 48347/99 A AU48347/99 A AU 48347/99A AU 4834799 A AU4834799 A AU 4834799A AU 4834799 A AU4834799 A AU 4834799A
Authority
AU
Australia
Prior art keywords
gene
variants
human
expressed
products
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48347/99A
Inventor
Mina Bissell
Huei-Mei Chen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
HUEI MEI CHEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HUEI MEI CHEN filed Critical HUEI MEI CHEN
Publication of AU4834799A publication Critical patent/AU4834799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
AU48347/99A 1998-06-26 1999-06-25 Human az-1 gene, variants thereof and expressed gene products Abandoned AU4834799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9074798P 1998-06-26 1998-06-26
US60090747 1998-06-26
PCT/US1999/014482 WO2000000503A1 (en) 1998-06-26 1999-06-25 Human az-1 gene, variants thereof and expressed gene products

Publications (1)

Publication Number Publication Date
AU4834799A true AU4834799A (en) 2000-01-17

Family

ID=22224118

Family Applications (1)

Application Number Title Priority Date Filing Date
AU48347/99A Abandoned AU4834799A (en) 1998-06-26 1999-06-25 Human az-1 gene, variants thereof and expressed gene products

Country Status (2)

Country Link
AU (1) AU4834799A (en)
WO (1) WO2000000503A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003213662A1 (en) * 2002-03-01 2003-09-16 Exelixis, Inc. Mbcats as modifiers of the beta-catenin pathway and methods of use
JP6170047B2 (en) 2011-08-31 2017-07-26 ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド Apoptosis-targeting nanoparticles
ES2669561T3 (en) 2012-02-17 2018-05-28 University Of Georgia Research Foundation, Inc. Nanoparticles for mitochondrial transport of agents
WO2015138992A1 (en) 2014-03-14 2015-09-17 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate

Also Published As

Publication number Publication date
WO2000000503A1 (en) 2000-01-06

Similar Documents

Publication Publication Date Title
AU6503299A (en) High-beta-conglycinin products and their use
AU4053699A (en) Novel human genes and gene expression products
AU4187499A (en) Human genes and gene expression products v
AU2001257453A1 (en) Product feature and relation comparison system
AU2001249125A1 (en) Human fgf-23 gene and gene expression products
AU2001245535A1 (en) Human fgf-23 gene and gene expression products
AUPP466598A0 (en) Product and process
AU4117000A (en) Cosmetic product and its use
AU3072500A (en) Rhamnosyl-transferase gene and uses thereof
AU5471600A (en) Variant tlr4 nucleic acid and uses thereof
AU6263400A (en) Polyisocyanate-polyaddition products
AU1101901A (en) Human fgf-20 gene and gene expression products
GB9928490D0 (en) Products and processes therefor
AU4329300A (en) Human mesenchymal dnas and expression products
AU1064800A (en) Products and methods
AU1029500A (en) Pharmaceutical and/or diet product
AU4834799A (en) Human az-1 gene, variants thereof and expressed gene products
AU6263999A (en) Human genes and gene expression products
AU1894601A (en) Novel gene and use thereof
AUPQ248399A0 (en) Plant and product treatment
AU4153400A (en) Continuous pelletizer and spheronizer
AU6773200A (en) Egfh2 genes and gene products
AU6558298A (en) Clock gene and gene product
AU5088600A (en) Gene therapy products
AU3900000A (en) Human fgf gene and gene expression products

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase